Coated-platelets retain amyloid precursor protein on their surface

被引:42
作者
Prodan, CI
Szasz, R
Vincent, AS
Ross, ED
Dale, GL
机构
[1] Univ Oklahoma, Sch Med, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA
[3] Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Vet Adm Med Ctr, Oklahoma City, OK 73104 USA
关键词
coated-platelet; thrombin; convulxin; collagen; amyloid precursor protein; Alzheimer's disease;
D O I
10.1080/09537100500181913
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coated-Platelets are a subset of platelets produced by dual-agonist activation with collagen plus thrombin and are characterized by strong retention of several procoagulant, alpha-granule proteins on the cell surface. In this report we demonstrate that coated-platelets also retain full-length amyloid precursor protein (APP) on their surface in contrast to the cleavage of APP in platelets activated with a single agonist. In addition, western blot analysis indicated that APP is derivatized during coated-platelet synthesis. We subsequently measured coated-platelet production in patients with Alzheimer's disease (AD). Twenty-two AD patients showed a wide distribution of coated-platelet values; however the least impaired AD patients produced coated-platelets at a level significantly above that of aged controls (41.0 +/- 9.9 vs. 28.7 +/- 11.4%; mean +/- 1SD; p = 0.017). These findings suggest that coated-platelets may be a model of aberrant APP processing in early AD patients.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 21 条
[1]   Surface expression and functional characterization of α-granule factor V in human platelets:: effects of ionophore A23187, thrombin, collagen, and convulxin [J].
Alberio, L ;
Safa, O ;
Clemetson, KJ ;
Esmon, CT ;
Dale, GL .
BLOOD, 2000, 95 (05) :1694-1702
[2]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[3]   Platelet APP isoform ratios correlate with declining cognition in AD [J].
Baskin, F ;
Rosenberg, RN ;
Iyer, L ;
Hynan, L ;
Cullum, CM .
NEUROLOGY, 2000, 54 (10) :1907-1909
[4]   Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia Alzheimer type - A 2-year follow-up study [J].
Borroni, B ;
Colciaghi, F ;
Caltagirone, C ;
Rozzini, L ;
Broglio, L ;
Cattabeni, F ;
Di Luca, M ;
Padovani, A .
ARCHIVES OF NEUROLOGY, 2003, 60 (12) :1740-1744
[5]   Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface [J].
Dale, GL ;
Friese, P ;
Batar, P ;
Hamilton, SF ;
Reed, GL ;
Jackson, KW ;
Clemetson, KJ ;
Alberio, L .
NATURE, 2002, 415 (6868) :175-179
[6]  
DALE GL, 2005, IN PRESS J THROMBOSI
[7]   Activated Alzheimer disease platelets retain more beta amyloid precursor protein [J].
Davies, TA ;
Long, HJ ;
Sgro, K ;
Rathbun, WH ;
McMenamin, ME ;
Seetoo, K ;
Tibbles, H ;
Billingslea, AM ;
Fine, RE ;
Fishman, JB ;
Levesque, CA ;
Smith, SJ ;
Wells, JM ;
Simons, ER .
NEUROBIOLOGY OF AGING, 1997, 18 (02) :147-153
[8]   Moderate and advanced Alzheimer's patients exhibit platelet activation differences [J].
Davies, TA ;
Long, HJ ;
Tibbles, HE ;
Sgro, KR ;
Wells, JM ;
Rathbun, WH ;
Seetoo, KF ;
McMenamin, ME ;
Smith, SJ ;
Feldman, RG ;
Levesque, CA ;
Fine, RE ;
Simons, ER .
NEUROBIOLOGY OF AGING, 1997, 18 (02) :155-162
[9]   NON-AGE RELATED DIFFERENCES IN THROMBIN RESPONSES BY PLATELETS FROM MALE-PATIENTS WITH ADVANCED ALZHEIMERS-DISEASE [J].
DAVIES, TA ;
FINE, RE ;
JOHNSON, RJ ;
LEVESQUE, CA ;
RATHBUN, WH ;
SEETOO, KF ;
SMITH, SJ ;
STROHMEIER, G ;
VOLICER, L ;
DELVA, L ;
SIMONS, ER .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :537-543
[10]   Differential level of platelet amyloid β precursor protein isoforms -: An early marker for Alzheimer disease [J].
Di Luca, M ;
Pastorino, L ;
Bianchetti, A ;
Perez, J ;
Vignolo, LA ;
Lenzi, GL ;
Trabucchi, M ;
Cattabeni, F ;
Padovani, A .
ARCHIVES OF NEUROLOGY, 1998, 55 (09) :1195-1200